The health of almost 12,000 children living with HIV across Namibia has rapidly improved due to dolutegravir medication.

The child version of the HIV drug was introduced in July 2021 by the Ministry of Health and Social Services in partnership with the U.S. government.

Dolutegravir, or DTG, has proven to be more effective in treating HIV and less likely to cause side effects in children.

However, according to a media release by the US Embassy in Namibia, there are still challenges to treating and caring for children living with HIV.